We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > combination treatment

News List

Novartis phase II data for new inhaled combination treatment (QVM149) demonstrates significant improvements over current standard-of-care inhaled treatment worldpharmanews
May 24, 2019
Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol acetate ...
Vertex wins European approval for new cystic fibrosis combination pharmaphorum
December 17, 2018
European regulators have approved Vertex’s new cystic fibrosis (CF) combination treatment Symkevi.The European Commission’s greenlight for Symkevi (tezacaftor/ivacaftor) will allow.....